{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:56:32Z","timestamp":1779256592786,"version":"3.51.4"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,11,20]],"date-time":"2016-11-20T00:00:00Z","timestamp":1479600000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s00198-016-3840-z","type":"journal-article","created":{"date-parts":[[2016,11,19]],"date-time":"2016-11-19T19:04:31Z","timestamp":1479582271000},"page":"1145-1147","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0761-4385","authenticated-orcid":false,"given":"A.","family":"S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,20]]},"reference":[{"issue":"Suppl 1","key":"3840_CR1","first-page":"S23","volume":"8","author":"H Fleisch","year":"1987","unstructured":"Fleisch H (1987) Bisphosphonates\u2014history and experimental basis. Bone 8(Suppl 1):S23\u2013S28","journal-title":"Bone"},{"key":"3840_CR2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/jbmr.2708","volume":"31","author":"RA Adler","year":"2016","unstructured":"Adler RA, El-Hajj Fuleihan G, Bauer DC et al (2016) Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a Task Force of the American Society for Bone and Mineral Research. J Bone Miner Res 31:16\u201335","journal-title":"J Bone Miner Res"},{"key":"3840_CR3","first-page":"145","volume":"8","author":"A S\u00e1nchez","year":"2008","unstructured":"S\u00e1nchez A (2008) [What are atypical femoral fractures?] (editorial; Spanish). Actual Osteol 8:145\u2013149","journal-title":"Actual Osteol"},{"key":"3840_CR4","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero SL, Dodson TB, Fantasia J et al (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 update. J Oral Maxillofac Surg 72:1938\u20131956","journal-title":"J Oral Maxillofac Surg"},{"key":"3840_CR5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/BOT.0000000000000516","volume":"30","author":"Y Bogdan","year":"2016","unstructured":"Bogdan Y, Tornetta P 3rd, Einhorn TA et al (2016) Healing time and complications in operatively treated atypical femur fractures associated with bisphosphonate use: a multicenter retrospective cohort. J Orthop Trauma 30:177\u2013181","journal-title":"J Orthop Trauma"},{"key":"3840_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.1998","volume":"29","author":"E Shane","year":"2014","unstructured":"Shane E, Burr D, Abrahamsen B et al (2014) Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 29:1\u201323","journal-title":"J Bone Miner Res"},{"key":"3840_CR7","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1136\/annrheumdis-2013-205080","volume":"73","author":"M Kharazmi","year":"2014","unstructured":"Kharazmi M, Hallberg P, Micha\u00eblsson K (2014) Gender related difference in the risk of bisphosphonate associated atypical femoral fracture and osteonecrosis of the jaw (letter). Ann Rheum Dis 73:1594","journal-title":"Ann Rheum Dis"},{"key":"3840_CR8","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1007\/s00198-011-1804-x","volume":"22","author":"J Compston","year":"2011","unstructured":"Compston J (2011) Pathophysiology of atypical femoral fractures and osteonecrosis of the jaw (review). Osteoporos Int 22:2951\u20132961","journal-title":"Osteoporos Int"},{"key":"3840_CR9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","volume":"30","author":"AA Khan","year":"2015","unstructured":"Khan AA, Morrison A, Hanley DA et al (2015) Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res 30:3\u201323","journal-title":"J Bone Miner Res"},{"key":"3840_CR10","doi-asserted-by":"crossref","first-page":"E723","DOI":"10.1210\/jc.2012-4144","volume":"98","author":"WH Chiu","year":"2013","unstructured":"Chiu WH, Lee JJ, Tsai KS (2013) Atypical femoral fractures shortly after osteonecrosis of the jaw in a postmenopausal woman taking alendronate for osteoporosis. J Clin Endocrinol Metab 98:E723\u2013E726","journal-title":"J Clin Endocrinol Metab"},{"key":"3840_CR11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.11005\/jbm.2014.21.2.155","volume":"21","author":"Y Won","year":"2014","unstructured":"Won Y, Lim JR, Kim YH, Song HK, Yang KH (2014) Atypical femoral fracture combined with osteonecrosis of jaw during osteoporosis treatment with bisphosphonate. J Bone Metab 21:155\u2013160","journal-title":"J Bone Metab"},{"key":"3840_CR12","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/RLU.0000000000000746","volume":"40","author":"JE Kim","year":"2015","unstructured":"Kim JE, Yun M, Lim SK, Rhee Y (2015) Concurrent bisphosphonate-related bilateral atypical subtrochanteric fractures and osteonecrosis of the jaw on bone scintigraphy. Clin Nucl Med 40:450\u2013452","journal-title":"Clin Nucl Med"},{"key":"3840_CR13","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1002\/jbmr.103","volume":"25","author":"A Grey","year":"2010","unstructured":"Grey A, Bolland M, Wattie D, Horne A, Gamble G, Reid IR (2010) Prolonged antiresorptive activity of zoledronate: a randomized, controlled trial. J Bone Miner Res 25:2251\u20132255","journal-title":"J Bone Miner Res"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-016-3840-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-016-3840-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-016-3840-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,7,10]],"date-time":"2018-07-10T08:14:52Z","timestamp":1531210492000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-016-3840-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,20]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["3840"],"URL":"https:\/\/doi.org\/10.1007\/s00198-016-3840-z","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,20]]}}}